Change of Management in Polymer Factory Sweden AB (publ)

Polymer Factory Sweden AB (publ) today announced that CEO Elin Mignérus and the Company’s Board of Directors have mutually agreed to part ways. Elin Mignérus will step down from her position at the end of the year, effective December 30, 2025.

Mats Wallnér, who has served as Acting CEO since January 1, 2025, will continue in this role until further notice.

“The Board would like to thank Elin for her commitment and valuable contributions to Polymer Factory during her tenure. We wish her the best of success in her future endeavors,” said Eva Malmström, Chair of the Board of Polymer Factory.

This disclosure contains information that Polymer Factory is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 30-09-2025 15:00 CET.

Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.

For more information, please contact:
Mats Wallnér, Acting CEO
Phone: +46 (0) 70 951 95 06
E-mail: mats.wallner@polymerfactory.com

Läs mer på Cision